Activity in this selection hlm-investment-partners-579dd709
Rounds participated in 4
Confirmed lead rounds 0 2 roles undisclosed
New companies 4 First participation on record · 0 follow-on
Funding in participating rounds $68.6M 4 disclosed · full round size, not this investor’s share
Rounds 4 in this selection Sep 21 Novadip Biosciences A clinical-stage biotechnology company developing regenerative cell therapies and grafts to repair bone and other damaged tissues, including a pivotal-stage treatment for a rare pediatric bone disorder.
Participant Sep 1 Amyl Therapeutics Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease.
Participant Jul 20 Brenus Pharma Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
Role not disclosed Mar 31 Standing Ovation Produces high-quality casein from whey permeates using precision fermentation
Role not disclosed